What Happened
- Researchers from the Bose Institute (Kolkata) — an autonomous institute under the Department of Science and Technology (DST) — and Rutgers University (USA) have overturned the nearly 50-year-old "sigma (σ) cycle" model of bacterial gene regulation, publishing their findings in the Proceedings of the National Academy of Sciences (PNAS).
- The sigma cycle, established in the 1970s and built largely on observations of the E. coli σ70 factor, held that sigma factors bind RNA polymerase to initiate transcription and then dissociate after initiation to allow elongation.
- The new research demonstrated that in Bacillus subtilis, the principal sigma factor (σA) remains bound to RNA polymerase throughout transcription — it does not dissociate after initiation, directly contradicting the universal applicability of the sigma cycle.
- A similar finding was observed for a truncated variant of E. coli's σ70 factor, suggesting the phenomenon extends beyond a single bacterial species.
- The discovery was made using a combination of biochemical assays, chromatin immunoprecipitation (ChIP), and fluorescence-based real-time imaging, enabling direct observation of sigma factor behaviour during active transcription.
- The finding has immediate implications for antibiotic development, as bacterial transcription machinery — particularly sigma factors — is a validated drug target for novel antibiotics.
Static Topic Bridges
Bacterial Gene Regulation and the Central Dogma of Molecular Biology
Molecular biology is governed by the central dogma: DNA is transcribed into RNA, which is translated into proteins. In bacteria, gene expression is regulated primarily at the transcription initiation step, where specific proteins control when and how genes are "switched on." Sigma factors are the primary class of transcription initiation regulators in bacteria.
- Sigma (σ) factors: Dissociable subunits of bacterial RNA polymerase that enable the core enzyme to recognise specific promoter DNA sequences and initiate transcription at the correct location.
- The σ cycle (classic model): Sigma factor binds to core RNA polymerase → the holoenzyme (RNA polymerase + sigma factor) binds promoter DNA → transcription initiates → sigma factor dissociates from RNA polymerase → RNA polymerase elongates the RNA transcript alone.
- Different sigma factors recognise different promoters, allowing bacteria to coordinate gene expression in response to stress, nutrient availability, and environmental signals.
- E. coli σ70 (encoded by the rpoD gene) is the primary or "housekeeping" sigma factor responsible for transcription of most genes under normal growth conditions.
- Bacillus subtilis σA is the functional equivalent of σ70 in a Gram-positive bacterium — a model organism for studying bacterial differentiation and sporulation.
Connection to this news: The new discovery shows that the sigma factor (specifically σA in Bacillus subtilis) does not follow the release step of the classic cycle — it persists on RNA polymerase throughout elongation. This rewrites a foundational textbook principle of bacterial molecular biology.
Implications for Antibiotic Development
Bacterial RNA polymerase is the target of the antibiotic rifampicin (rifampin), one of the key first-line drugs for tuberculosis treatment. The discovery of non-canonical sigma factor behaviour opens new avenues for designing antibiotics that target the sigma factor–RNA polymerase interface during elongation, not just initiation — a previously unexploited drug target.
- Rifampicin: An RNA polymerase inhibitor that blocks the elongation of RNA chains; used for tuberculosis, leprosy, and some other bacterial infections. Rifampicin resistance is a major clinical problem, especially in multidrug-resistant tuberculosis (MDR-TB).
- India has one of the world's highest tuberculosis burdens: approximately 2.8 million new TB cases per year (Global TB Report 2024), accounting for about 26% of global TB cases.
- The WHO's End TB Strategy targets a 90% reduction in TB incidence and a 95% reduction in TB deaths by 2030 compared to 2015 baseline.
- Antimicrobial resistance (AMR) is projected to cause 10 million deaths per year globally by 2050 if current trends continue (O'Neill Commission Report).
- New antibiotic discovery has slowed dramatically since the 1980s ("discovery void"), making mechanistic breakthroughs like this critical for identifying novel drug targets.
Connection to this news: If sigma factors remain bound during elongation in key pathogenic bacteria, they represent a structurally stable drug target throughout the transcription cycle — not just at initiation — potentially enabling a new class of sigma factor inhibitors.
Indian Science Institutions and the DST Ecosystem
The Bose Institute, Kolkata, is named after Jagadish Chandra Bose, India's pioneering scientist. It is an autonomous institution under the Department of Science and Technology (DST) and is one of India's oldest research institutes (established 1917). India's science and technology governance involves DST, CSIR (Council of Scientific and Industrial Research), DBT (Department of Biotechnology), and ICMR (Indian Council of Medical Research) as the primary funding and oversight bodies for basic and applied research.
- PNAS (Proceedings of the National Academy of Sciences): One of the world's most-cited and prestigious multidisciplinary scientific journals, published by the National Academy of Sciences (USA). Publication here indicates the research passed rigorous international peer review.
- DST: The nodal government body for formulating science and technology policy; administers autonomous research institutions, national labs, and research fellowships.
- CSIR: Has 37 national laboratories; focuses on applied/industrial research. CSIR-NIScPR (also in the news) is a communications and policy research institute under CSIR — distinct from DST's Bose Institute.
- India ranks third globally in research output (number of scientific publications) as of 2022 (Nature Index), reflecting rapid growth in domestic research capacity.
Connection to this news: The India-USA collaboration between Bose Institute and Rutgers University reflects the growing pattern of Indian research institutions contributing to global frontier science discoveries, with international co-authorship amplifying impact.
Key Facts & Data
- Discovery: Sigma factor (σA) in Bacillus subtilis remains bound to RNA polymerase throughout transcription — does not dissociate after initiation as the classic sigma cycle predicted
- Research institutions: Bose Institute, Kolkata (under DST) + Rutgers University, USA
- Published in: PNAS (Proceedings of the National Academy of Sciences)
- Classic sigma cycle model: Established ~1970s, built on E. coli σ70 observations
- Methods used: Biochemical assays, chromatin immunoprecipitation (ChIP), fluorescence-based imaging
- Key antibiotic implication: Opens new drug targets at the sigma factor–RNA polymerase interface during elongation
- Rifampicin: Current RNA polymerase-targeting antibiotic; critical for TB treatment
- India TB burden: ~2.8 million new cases/year (~26% of global total, Global TB Report 2024)
- Bose Institute: Established 1917, Kolkata; one of India's oldest research institutes
- AMR global mortality projection: 10 million deaths/year by 2050 (O'Neill Commission)